CN110441463A - A kind of reagent of ion exchange chromatography detection Glycohemoglobin HbA1c - Google Patents
A kind of reagent of ion exchange chromatography detection Glycohemoglobin HbA1c Download PDFInfo
- Publication number
- CN110441463A CN110441463A CN201910599335.2A CN201910599335A CN110441463A CN 110441463 A CN110441463 A CN 110441463A CN 201910599335 A CN201910599335 A CN 201910599335A CN 110441463 A CN110441463 A CN 110441463A
- Authority
- CN
- China
- Prior art keywords
- reagent
- preservative
- eluent
- ion exchange
- disodium hydrogen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/96—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation using ion-exchange
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
The invention discloses a kind of reagents of ion exchange chromatography detection Glycohemoglobin HbA1c, including following solution: the main ingredient of A eluent is the disodium hydrogen phosphate of 0.2~1g/L, the sodium dihydrogen phosphate of 0.5~1.5g/L, the potassium chloride of 0.2~1g/L and the preservative of 0.02~0.4g/L, pH range is 6.1~7.1, the main ingredient of B eluent is the disodium hydrogen phosphate of 0.2~1g/L, the sodium dihydrogen phosphate of 0.5~1.5g/L, the potassium chloride of 0.2~1g/L, the sodium chloride of 1~5g/L and the preservative of 0.02~0.4g/L, and pH is 6.1~7.1.Reagent raw material sources of the present invention are easy to get extensively, and harmless, preparation process is simple, without complicated manufacture craft, finished product reagent can store under normal temperature conditions, and detecting step is convenient, reagent need to be only placed on necessary instrument, with the use of test result can be gone out.
Description
Technical field
The present invention relates to glycosylated hemoglobin detection technique field in medical test, specially a kind of ion exchange chromatography
Detect the reagent of Glycohemoglobin HbA1c.
Background technique
Glycohemoglobin HbA1c be glucose in hemoglobin and blood in red blood cell slowly, continue and can not
The product of back reaction, its concentration is relative constant, is able to reflect the nearly 2-3 monthly average blood glucose level of body currently, as international sugar
The American Diabetes Association (ADA) of one of urine disease research authoritative institution is as the goldstandard of blood glucose control.It is to sugar
The screening, diagnosis, observation of curative effect for urinating disease have a very important significance.
Glycosylated hemoglobin measuring method up to more than 60, is broadly divided into two major classes: the detection side 1. based on charge differences
Method, including ion-exchange chromatography, efficient liquid phase chromatographic analysis and electrophoresis etc.;2. the detection method based on architectural difference, including
Affinity chromatography and immunization etc..
Affinity chromatography achievees the purpose that separation determination in conjunction with the glucose specificity in HbA1c residue using it, and
It is minimum by glycosylated hemoglobin variant and derivative interference, as long as but have glycosylation structure on haemoglobin molecule, can
It is captured by affinity column, therefore the testing result of this method is glycosylated hemoglobin total amount, it is more higher than other methods measured value.
Immunization inhibits principle to quantitative determine HbA1c using antibody-mediated latex agglutination, but vulnerable to many homologous sugar
Change the interference of haemoglobin variant, and corresponding reagent raw material needs to use the antibody antigen of animality, price is partially expensive, need to also be low
It is saved under the conditions of temperature, transportation cost is also higher.
Electrophoresis is separated, electrophoresis according to the glycosylated hemoglobin difference electrically charged with both the non-glycated hemoglobin
After, Hb H b each component is HbA1a, HbA1b, HbA1c, HbA respectively from cathode to anode0.It is swept by absorbance
It retouches, the percentage composition of HbA1c can be calculated.But the shortcomings that the method is need to carry out sample analysis in batch, and speed is slow,
It can not be measured in real time, the degree of automation is low, and the functions such as emergency treatment insertion, automatic maintenance compare shortcoming.
Ion-exchange high-performance liquid chromatography analytic approach is to detect the goldstandard of Glycohemoglobin HbA1c, it is based on blood
The electrically charged difference of institute after the saccharification of hemoglobin beta chain N-terminal valine is different from the adhesive force of cation exchange resin and establish.Cause
This can be distinguished different component by HPLC method, be separated, and with detector to the various hemoglobin components after separation
Absorbance detected, after analysis, various hemoglobin component results expressed as a percentage.
Reagent and its principle in the present invention is eluent and hemolytic agent with Ion-exchange high-performance liquid chromatography analytic approach
Composition, wherein processing product of the hemolytic agent as sample makes the membranolysis in whole blood sample and release whole blood sample
In hemoglobin, play the role of rupture of membranes, do not occur chemically react and generate new chemical substance.Cation in chromatographic column
Exchanger resin is because having certain cationic polar after its activation, from glycosylated hemoglobin, the sugar of charges different in whole blood sample
Change haemoglobin variant and both the non-glycated hemoglobin forms the ionic bond of certain strong and weak difference, when the elution of specific pH intensity
When liquid is by the chromatographic column that is adsorbed with whole blood sample, then the glycosylated hemoglobin that ionic bond can be made weaker takes the lead in washing from chromatographic column
It is de- to separate, and glycosylated hemoglobin variant and both the non-glycated hemoglobin be then because binding force is stronger, can only by pH intensity compared with
High eluent elutes by several times, and therefore, the eluent in the present invention does not occur biological or chemical with whole blood sample and reacts,
Only a kind of absorption, displacement, the process being detached from.
Summary of the invention
(1) the technical issues of solving
In view of the deficiencies of the prior art, the present invention provides a kind of ion exchange chromatographies to detect glycosylated hemoglobin
The reagent of HbA1c solves the problems in above-mentioned background technique.
(2) technical solution
To achieve the above object, the invention provides the following technical scheme: a kind of ion exchange chromatography detects HbAle
The reagent of albumen HbA1c, including following solution:
The main ingredient of A eluent is the disodium hydrogen phosphate of 0.2~1g/L, the sodium dihydrogen phosphate of 0.5~1.5g/L, 0.2
The potassium chloride of~1g/L and the preservative of 0.02~0.4g/L, pH range are 6.1~7.1.
The main ingredient of B eluent is the disodium hydrogen phosphate of 0.2~1g/L, the sodium dihydrogen phosphate of 0.5~1.5g/L, 0.2
The preservative of the potassium chloride of~1g/L, the sodium chloride of 1~5g/L and 0.02~0.4g/L, pH are 6.1~7.1.
The main ingredient of C eluent is the disodium hydrogen phosphate of 0.2~1g/L, the sodium dihydrogen phosphate of 0.5~1.5g/L, 0.2
The potassium chloride of~1g/L, the sodium chloride of 2~10g/L, 0.02~0.4g/L preservative, pH be 5.9~6.9.
The main ingredient of D eluent is the disodium hydrogen phosphate of 0.2~1g/L, the sodium dihydrogen phosphate of 0.5~1.5g/L, 10
The sodium chloride of~20g/L and the preservative of 0.02~0.4g/L, pH are 6.1~7.1.
The main component of hemolytic agent is the surfactant of the boric acid of 15~30g/L, the borax of 5~20g/L, 1~5g/L
With the preservative of 0.02~0.4g/L, pH is 7.0~8.0.
It is anti-corrosion agent addition agent of the present invention that wherein present invention selection content, which is 0.01% to 99.9% methylisothiazolinone,.
The technical program is advanced optimized, the substitution ingredient of the surfactant has Triton-X100, Brj-35, gathers
Ethylene glycol.
(3) beneficial effect
Compared with prior art, the present invention provides a kind of ion exchange chromatography detection Glycohemoglobin HbA1cs
Reagent, have it is following the utility model has the advantages that
1, the reagent of ion exchange chromatography detection Glycohemoglobin HbA1c, reagent raw material sources are easy to get extensively, right
Human body is harmless, and preparation process is simple, and without complicated manufacture craft, finished product reagent can store under normal temperature conditions.
2, the reagent of ion exchange chromatography detection Glycohemoglobin HbA1c, detecting step is convenient, only need to be by reagent
It is placed on necessary instrument, with the use of test result can be gone out.
Detailed description of the invention
Fig. 1 is invention test effect figure.
Specific embodiment
Below in conjunction with the embodiment of the present invention, present invention is further described in detail:
Embodiment 1
Note: "-", which represents, is free of this ingredient;
Embodiment 2
Note: "-", which represents, is free of this ingredient;
Embodiment 3
Note: "-", which represents, is free of this ingredient;
Simultaneously based in the present embodiment 1,2,3 respectively at being grouped as and according to People's Republic of China's pharmaceuticals industry standard
Repeatability, linear and accuracy clause should be met the following requirements in YY/T1246-2014 " glycolated hemoglobin analysis ":
Repeatability: the sample that measurement concentration is 4.0%~6.5%, METHOD FOR CONTINUOUS DETERMINATION 20 times, the repeated measuring results coefficient of variation
CV should be not more than 3.0%;
Linear: in detection interval, the linearly dependent coefficient r of testing result should be not less than 0.9900;
Accuracy: it is measured with nominal reference substance, the abnormal reference material that can trace to the source to IFCC or NGSP, relatively partially
Difference should be in ± 8% section;
Test data:
1, repeated
Embodiment 1:
Embodiment 2:
Embodiment 3:
2, linear
Embodiment 1:
Embodiment 2:
Embodiment 3:
3, accuracy
Embodiment 1:
Embodiment 2:
Embodiment 3:
As can be seen from the above results, agent prescription of the present invention is matched with existing instrument, and testing result meets
Industry code requirements.
From Figure of description 1 as can be seen that agent prescription of the invention can isolate HbA1a, HbA1b, HbA1c,
HbA0 component, the testing result of Glycohemoglobin HbA1c have 3 kinds of representation methods, American National glycosylated hemoglobin standard meter
Draw (NGSP) unit (%) and international clinical chemistry association (IFCC) unit (mmol/mol) and average blood sugar (eAG) unit
(mmol/L)。
Meanwhile being found after a large amount of selection test, existing preservative is being used for liquid chromatography color on the market at present
It all can be to microballoon filler inside liquid chromatography chromatography column and chromatographic column when composing the elution reagent or other matched reagents of column
Service life and performance have an immense impact on, and performance is to make the filler nigrescence of liquid chromatography chromatographic column and block microballoon inside chromatographic column
Gap between filler, causes that the pressure of entire liquid chromatography chromatographic system quickly increases or filler is displaced to form chromatographic column gap
Shape, so that original service life of chromatographic column and the decline of filling adsorption ability, and use methylisothiazolinone as liquid chromatogram layer
Problems are just not present in the eluent or matched reagent for analysing column, similar with the antiseptic property of Sodium azide, select new preservative
The main reason for be because Sodium azide belongs to and meets water and generate extremely toxic substance, and in strenuous vibration and 40 DEG C under dry powder
Above environment is easy to happen explosion, be easy to cause environmental pollution and personal injury.
Technical characteristic of the present invention without description can realize that details are not described herein by or using the prior art, certainly,
Above-mentioned specific embodiment is not limitation of the present invention, and the present invention is also not limited to above-mentioned specific embodiment, this skill
The variations, modifications, additions or substitutions that the those of ordinary skill in art field is made within the essential scope of the present invention should also be fallen into
In protection scope of the present invention.
Claims (2)
1. a kind of reagent of ion exchange chromatography detection Glycohemoglobin HbA1c, it is characterised in that: including following solution:
The main ingredient of A eluent is the disodium hydrogen phosphate of 0.2~1g/L, the sodium dihydrogen phosphate of 0.5~1.5g/L, 0.2~1g/
The potassium chloride of L and the preservative of 0.02~0.4g/L, pH range are 6.1~7.1;
The main ingredient of B eluent is the disodium hydrogen phosphate of 0.2~1g/L, the sodium dihydrogen phosphate of 0.5~1.5g/L, 0.2~1g/
The preservative of the potassium chloride of L, the sodium chloride of 1~5g/L and 0.02~0.4g/L, pH are 6.1~7.1;
The main ingredient of C eluent is the disodium hydrogen phosphate of 0.2~1g/L, the sodium dihydrogen phosphate of 0.5~1.5g/L, 0.2~1g/
The potassium chloride of L, the sodium chloride of 2~10g/L, 0.02~0.4g/L preservative, pH be 5.9~6.9;
The main ingredient of D eluent is the disodium hydrogen phosphate of 0.2~1g/L, the sodium dihydrogen phosphate of 0.5~1.5g/L, 10~20g/
The sodium chloride of L and the preservative of 0.02~0.4g/L, pH are 6.1~7.1;
The main component of hemolytic agent be the boric acid of 15~30g/L, the borax of 5~20g/L, 1~5g/L surfactant and
The preservative of 0.02~0.4g/L, pH are 7.0~8.0.
It is anti-corrosion agent addition agent of the present invention that wherein present invention selection content, which is 0.01% to 99.9% methylisothiazolinone,.
2. a kind of reagent of ion exchange chromatography detection Glycohemoglobin HbA1c according to claim 1, feature
Be: the substitution ingredient of the surfactant has Triton-X100, Brj-35, polyethylene glycol.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910599335.2A CN110441463A (en) | 2019-07-04 | 2019-07-04 | A kind of reagent of ion exchange chromatography detection Glycohemoglobin HbA1c |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201910599335.2A CN110441463A (en) | 2019-07-04 | 2019-07-04 | A kind of reagent of ion exchange chromatography detection Glycohemoglobin HbA1c |
Publications (1)
Publication Number | Publication Date |
---|---|
CN110441463A true CN110441463A (en) | 2019-11-12 |
Family
ID=68429057
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201910599335.2A Pending CN110441463A (en) | 2019-07-04 | 2019-07-04 | A kind of reagent of ion exchange chromatography detection Glycohemoglobin HbA1c |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN110441463A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110887916A (en) * | 2019-12-21 | 2020-03-17 | 江苏奥迪康医学科技股份有限公司 | Reagent matched with glycosylated hemoglobin high-pressure liquid chromatography analyzer |
CN114712894A (en) * | 2022-04-08 | 2022-07-08 | 无锡博慧斯生物医药科技有限公司 | Activation liquid, activation method and application of glycosylated hemoglobin chromatographic column |
CN115372486A (en) * | 2021-05-18 | 2022-11-22 | 深圳市帝迈生物技术有限公司 | Glycosylated hemoglobin detection kit and application thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102226788A (en) * | 2011-04-06 | 2011-10-26 | 江苏奥迪康医学科技有限公司 | Four-gradient elution analysis method of glycated hemoglobin analyzer |
CN103076214A (en) * | 2012-12-26 | 2013-05-01 | 宁波美康生物科技股份有限公司 | Preparation method of glycosylated hemoglobin quality control |
CN103969375A (en) * | 2013-01-29 | 2014-08-06 | 深圳普门科技有限公司 | An elution method for liquid chromatography and inspection equipment thereof |
CN104865326A (en) * | 2015-05-28 | 2015-08-26 | 江苏奥迪康医学科技有限公司 | Three-gradient elution analysis method of glycosylated hemoglobin analyzer |
CN106546455A (en) * | 2015-09-16 | 2017-03-29 | 深圳迈瑞生物医疗电子股份有限公司 | Hemolytic agent, the method for the pretreatment of biological sample, the assay method of object content and kit |
CN107015007A (en) * | 2017-03-29 | 2017-08-04 | 苏州康铭诚业医用科技有限公司 | A kind of hemoglobin concentration hemolytic agent |
CN107884588A (en) * | 2017-11-13 | 2018-04-06 | 重庆艾维迪生物科技有限公司 | Hemolytic agent for detecting glycosylated hemoglobin and its preparation method and application |
-
2019
- 2019-07-04 CN CN201910599335.2A patent/CN110441463A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102226788A (en) * | 2011-04-06 | 2011-10-26 | 江苏奥迪康医学科技有限公司 | Four-gradient elution analysis method of glycated hemoglobin analyzer |
CN103076214A (en) * | 2012-12-26 | 2013-05-01 | 宁波美康生物科技股份有限公司 | Preparation method of glycosylated hemoglobin quality control |
CN103969375A (en) * | 2013-01-29 | 2014-08-06 | 深圳普门科技有限公司 | An elution method for liquid chromatography and inspection equipment thereof |
CN104865326A (en) * | 2015-05-28 | 2015-08-26 | 江苏奥迪康医学科技有限公司 | Three-gradient elution analysis method of glycosylated hemoglobin analyzer |
CN106546455A (en) * | 2015-09-16 | 2017-03-29 | 深圳迈瑞生物医疗电子股份有限公司 | Hemolytic agent, the method for the pretreatment of biological sample, the assay method of object content and kit |
CN107015007A (en) * | 2017-03-29 | 2017-08-04 | 苏州康铭诚业医用科技有限公司 | A kind of hemoglobin concentration hemolytic agent |
CN107884588A (en) * | 2017-11-13 | 2018-04-06 | 重庆艾维迪生物科技有限公司 | Hemolytic agent for detecting glycosylated hemoglobin and its preparation method and application |
Non-Patent Citations (2)
Title |
---|
郭喜 等: "糖化血红蛋白实验室检测技术及方法学进展", 《临床输血与检验》 * |
黄倩云 等: "体外诊断试剂防腐剂的选择策略", 《生物技术通讯》 * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110887916A (en) * | 2019-12-21 | 2020-03-17 | 江苏奥迪康医学科技股份有限公司 | Reagent matched with glycosylated hemoglobin high-pressure liquid chromatography analyzer |
CN115372486A (en) * | 2021-05-18 | 2022-11-22 | 深圳市帝迈生物技术有限公司 | Glycosylated hemoglobin detection kit and application thereof |
CN114712894A (en) * | 2022-04-08 | 2022-07-08 | 无锡博慧斯生物医药科技有限公司 | Activation liquid, activation method and application of glycosylated hemoglobin chromatographic column |
CN114712894B (en) * | 2022-04-08 | 2024-04-30 | 无锡博慧斯生物医药科技有限公司 | Activating solution, activating method and application of glycosylated hemoglobin chromatographic column |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Shima et al. | High-performance liquid chromatographic assay of serum glycated albumin | |
Parker et al. | Improved colorimetric assay for glycosylated hemoglobin. | |
Rohlfing et al. | The effect of elevated fetal hemoglobin on hemoglobin A1c results: five common hemoglobin A1c methods compared with the IFCC reference method | |
CN110441463A (en) | A kind of reagent of ion exchange chromatography detection Glycohemoglobin HbA1c | |
Ellis et al. | An automated" high-pressure" liquid-chromatographic assay for hemoglobin A1c. | |
Yue et al. | The measurement of glycosylated hemoglobin in man and animals by aminophenylboronic acid affinity chromatography | |
Gould et al. | A sensitive method for the measurement of glycosylated plasma proteins using affinity chromatography | |
CN109633010B (en) | Kit and method for measuring glycosylated hemoglobin in whole blood | |
Gould et al. | Measurement of glycosylated haemoglobins using an affinity chromatography method | |
Chachou et al. | Influence of in vivo hemoglobin carbamylation on HbA1c measurements by various methods | |
JP2619537B2 (en) | Liquid chromatography method, apparatus, system, and separation column | |
CN103197084A (en) | Stable glycated serum protein detection reagent and application thereof | |
Schellekens et al. | Sources of variation in the column-chromatographic determination of glycohemoglobin (HbA1). | |
Yatscoff et al. | Interference of fetal hemoglobin and labile glycosylated hemoglobin with measurements of glycosylated hemoglobin. | |
JPH0477500A (en) | Method for separating glycohemoglobin and separation device therefor | |
Smith et al. | Glycosylated and carbamylated haemoglobin in uraemia | |
Motinaro | Targeting HbA1c: standardization and clinical laboratory measurement. | |
Aleyassine et al. | Agar gel electrophoretic determination of glycosylated hemoglobin: effect of variant hemoglobins, hyperlipidemia, and temperature. | |
Kato et al. | Rapid pretreatment for multi-sample analysis of advanced glycation end products and their role in nephropathy | |
Hjerpe | Liquid-chromatographic determination of hyaluronic acid in pleural and ascitic fluids. | |
Koskinen | Specificity of hemoglobin A1c measurement by cation exchange liquid chromatography. Evaluation of a Mono S column method | |
Gilbert et al. | Interlaboratory variation of GHb assays in Victoria, Australia | |
Cohen et al. | Purified haemoglobin preparations in the evaluation of HbA1c determination by ion exchange chromatography | |
CN110806450B (en) | Liquid calibrator for glycosylated hemoglobin | |
Song et al. | Comparability of different methods of glycated hemoglobin measurement for samples of patients with variant and non-variant hemoglobin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |